Journal
VIRUSES-BASEL
Volume 11, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/v11030290
Keywords
alphavirus; arthralgia; chikungunya; Ross River virus; emerging virus; mosquito-borne
Categories
Funding
- Australian National Health and Medical Research Council [1122897]
- National Health and Medical Research Council of Australia [1122897] Funding Source: NHMRC
Ask authors/readers for more resources
Arthritogenic alphaviruses are a group of medically important arboviruses that cause inflammatory musculoskeletal disease in humans with debilitating symptoms, such as arthralgia, arthritis, and myalgia. The arthritogenic, or Old World, alphaviruses are capable of causing explosive outbreaks, with some viruses of major global concern. At present, there are no specific therapeutics or commercially available vaccines available to prevent alphaviral disease. Infected patients are typically treated with analgesics and non-steroidal anti-inflammatory drugs to provide often inadequate symptomatic relief. Studies to determine the mechanisms of arthritogenic alphaviral disease have highlighted the role of the host immune system in disease pathogenesis. This review discusses the current knowledge of the innate immune response to acute alphavirus infection and alphavirus-induced immunopathology. Therapeutic strategies to treat arthritogenic alphavirus disease by targeting the host immune response are also examined.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available